Key result
TAVI rollout linked to ~4% lower cardiac-origin OHCA incidence per 1,000 procedures in elderly adults.
Why the study?
While transcatheter aortic valve implantation improves individual outcomes in severe aortic stenosis, its population-level impact on cardiac-origin out-of-hospital cardiac arrest among very elderly adults was unclear.
Does the nationwide introduction of transcatheter aortic valve implantation (TAVI) reduce the incidence of cardiac-origin out-of-hospital cardiac arrest in adults aged 80 years and older?
Observational (n=577,265)
Yes
Does the nationwide introduction of transcatheter aortic valve implantation (TAVI) reduce the incidence of cardiac-origin out-of-hospital cardiac arrest in adults aged 80 years and older?
The nationwide rollout of TAVI in Japan was temporally and ecologically associated with a population-level reduction in cardiac-origin out-of-hospital cardiac arrest among adults aged 80 years and older.
Answers are grounded in this paper and cite their sources.
TAVI expansion was associated with lower cardiac OHCA in the elderly; hypothesis-generating and should not yet change practice.
Background: Severe aortic stenosis (AS) is increasingly prevalent in very elderly adults, contributing to sudden cardiac death. While transcatheter aortic valve implantation (TAVI) improves individual outcomes, its population-level impact on cardiac-origin out-of-hospital cardiac arrest (OHCA) is unclear. We quantified the population-level association between the nationwide introduction of TAVI in Japan and the incidence of cardiac-origin OHCA among adults aged ≥80 years. Methods: We conducted a population-based observational study using the All-Japan Utstein Registry (Jan 2007–Dec 2019), including 577,265 OHCA cases (474,300 cardiac-origin; 102,965 non-cardiac-origin) in patients aged 80–110 years. Annual age- and sex-standardized OHCA incidence was calculated. Analyses included: (1) interrupted time-series (ITS); (2) difference-in-differences (DID) comparing early-adopter versus other prefectures; and (3) mixed-effects negative binomial regression assessing associations between TAVI volume and subsequent OHCA incidence. Findings: Age- and sex-adjusted cardiac-origin OHCA incidence increased until 2014 (slope: 0·062 per 1,000 persons; 95% confidence interval [CI]: 0·041–0·083; p<0·001), and decreased in 2014 (−0·324; 95% CI: –0·449 to –0·199; p<0·001) with a continuing downward trend (−0·049; 95% CI: −0·076 to −0·023; p=0·002). Early-adopter prefectures experienced the greatest reductions (DID: −0·034; 95% CI: −0·068 to −0·000; p=0·049). Each additional 1,000 annual TAVI procedures was associated with a lower incidence of cardiac-origin OHCA the following year (incidence rate ratio: 0·956; 95% CI: 0·917–0·998; p=0·040). Interpretation: Nationwide TAVI rollout in Japan was temporally and ecologically associated with reduced cardiac-origin OHCA among very elderly adults, suggesting that TAVI may mitigate preventable sudden deaths at a population level in aging societies.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2026) conducted an observational in Out-of-hospital cardiac arrest (OHCA) and severe aortic stenosis (n=577,265). Nationwide transcatheter aortic valve implantation (TAVI) rollout vs. Pre-TAVI rollout period and non-early-adopter prefectures was evaluated on Age- and sex-standardized incidence of cardiac-origin out-of-hospital cardiac arrest (OHCA) (IRR 0.956 per 1,000 annual TAVI procedures, 95% CI 0.917-0.998, p=0.040). Nationwide TAVI rollout in Japan was associated with lower subsequent cardiac-origin OHCA incidence in adults aged ≥80 years.
Synapse has enriched 10 related papers. Consider them for comparative context: